Cover
Cover | Apr. 30, 2024 |
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Apr. 30, 2024 |
Entity File Number | 001-40064 |
Entity Registrant Name | Virpax Pharmaceuticals, Inc. |
Entity Central Index Key | 0001708331 |
Entity Tax Identification Number | 82-1510982 |
Entity Incorporation, State or Country Code | DE |
Entity Address, Address Line One | 1055 Westlakes Drive |
Entity Address, Address Line Two | Suite 300 |
Entity Address, City or Town | Berwyn |
Entity Address, State or Province | PA |
Entity Address, Postal Zip Code | 19312 |
City Area Code | 610 |
Local Phone Number | 727-4597 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock, par value $0.00001 per share |
Trading Symbol | VRPX |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | true |
Elected Not To Use the Extended Transition Period | false |